Use of Mefenamic Acid as a Supportive Treatment of COVID-19: A Repurposing Drug
International Journal of Science and Research (IJSR)

International Journal of Science and Research (IJSR)
www.ijsr.net | Open Access | Fully Refereed | Peer Reviewed International Journal

ISSN: 2319-7064

Informative Article | Medicine | India | Volume 9 Issue 6, June 2020

Use of Mefenamic Acid as a Supportive Treatment of COVID-19: A Repurposing Drug

Dr. R. P. Pareek

COVID-19 (coronavirus disease 2019) is a Pandemic of concern, caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). As of now, there is no known effective pharmaceutical or other medicine available for cure or prevention of COVID-19. In this review, based on the current understanding of the disease and the structure of novel Coronavirus SARS-CoV-2, SARS-CoV and other human viruses, I have identified Mefenamic Acid, an anti-inflammatory medicine, of having some role as an anti-viral medicine also. It can be used along with different anti-viral drugs being tried for the treatment of Covid 19. Since it is also an anti-pyretic, its main role may be of bringing down the fever but its action as an anti-viral, as a supportive medicine can very useful. Clincal trials with this concept in mind can be started immediately at the Centre dedicated for treatment of Covid 19.

Keywords: COVID-19, SARS-CoV-2, Mefenamic acid, serine protease inhibitor, NLRP3 inflammasome

Edition: Volume 9 Issue 6, June 2020

Pages: 69 - 73

Share this Article

How to Cite this Article?

Dr. R. P. Pareek, "Use of Mefenamic Acid as a Supportive Treatment of COVID-19: A Repurposing Drug", International Journal of Science and Research (IJSR), https://www.ijsr.net/search_index_results_paperid.php?id=SR20530150407, Volume 9 Issue 6, June 2020, 69 - 73

780 PDF Views | 182 PDF Downloads

Download Article PDF



Similar Articles with Keyword 'COVID-19'

Case Studies, Medicine, India, Volume 9 Issue 11, November 2020

Pages: 697 - 700

Treatment Strategies in Clinically and Radiologically Suspicious but Serologically Negative Cases of COVID-19 (Case Report)

Dr. Saurabh Tyagi, Dr. Frank P, Dr. Trinath Dash

Share this Article

Research Paper, Medicine, India, Volume 9 Issue 11, November 2020

Pages: 909 - 914

Clinical Profile of COVID-19 Patients and QT Interval Changes with Drugs used for Empirical Treatment: A Case Series from Eastern India

Dr. Pradip Saha, Dr Avijit Hazra

Share this Article

Review Papers, Medicine, India, Volume 9 Issue 9, September 2020

Pages: 1132 - 1135

Interleukin 6: The Best Marker for COVID-19 Disease Severity

Gagandeep Malik

Share this Article

Review Papers, Medicine, United States of America, Volume 9 Issue 10, October 2020

Pages: 1016 - 1020

Remdesivir: An Emergency Solution for the Treatment of Mild/Moderate and Severe COVID-19 Hospitalized Patients

Elizabeth Z Zakka

Share this Article

Review Papers, Medicine, Indonesia, Volume 9 Issue 8, August 2020

Pages: 960 - 965

Management of Urinary Incontinence and Alvi Incontinence in the COVID-19 Pandemic Era

I Gde Sastra Winata, I Putu Rian Cipta Pramana Putra

Share this Article

Similar Articles with Keyword 'SARS-CoV-2'

Research Paper, Medicine, India, Volume 9 Issue 11, November 2020

Pages: 909 - 914

Clinical Profile of COVID-19 Patients and QT Interval Changes with Drugs used for Empirical Treatment: A Case Series from Eastern India

Dr. Pradip Saha, Dr Avijit Hazra

Share this Article

Review Papers, Medicine, United States of America, Volume 9 Issue 10, October 2020

Pages: 1016 - 1020

Remdesivir: An Emergency Solution for the Treatment of Mild/Moderate and Severe COVID-19 Hospitalized Patients

Elizabeth Z Zakka

Share this Article

Review Papers, Medicine, India, Volume 9 Issue 11, November 2020

Pages: 45 - 51

COVID-19 Vaccination Strategies and Challenges - A Literature Review

Dr Vidit Majmundar, Dr Purva Shah

Share this Article

Informative Article, Medicine, India, Volume 9 Issue 6, June 2020

Pages: 69 - 73

Use of Mefenamic Acid as a Supportive Treatment of COVID-19: A Repurposing Drug

Dr. R. P. Pareek

Share this Article
Top